Media Statement and Declaration

Prof. Mohammed bin Hussein AlQahtani, the founder and the Director of Center of Excellence in Genomic Medicine Research, with a justified sense of proud, declared the opening and launching of GenaTi – a group of diagnostic laboratories in a glittering ceremony. Among a host of dignitaries from the universities and renowned medical houses, the Honorable Chief guest, His Excellency prof. Abdulrehman bin Obaid Al Ayoubi inaugurated GenaTi on Sunday 19-7-1438 AH. Many Deans, Scientists, Researchers and learned guests observed the function which took place in the premises of Center of Excellence of Genomic Medicine Research at King Fahd Medical Research Center. In the august gathering, the presence of many specialists interested in the field of Medical Diagnosis both from public sector and business houses, was another main attraction.

Prof. Mohammed bin Hussein AlQahtani, the Executive Director of GenaTi, in his opening statement explained the importance of the GenaTi project and announced that it was in line with the growing new aspirations of KSA vision 2030. He appreciated the encouragement and wise direction of the University Administration, as a whole, for grooming the Center of Excellence in Genomic Medicine Research and Center of Innovation in Personalized Medicine to, this stage where it has transformed itself into a competitive company, capable of marketing a number of diagnostic products at national and international level. A marvelous feet indeed. He expressed optimism that through GenaTi, as a extended commercial arm of the University, the excellence in the knowledge of science and research in Human Genome, will meet the highest level of aspirations.

Towards the end, he concluded that GenaTi is the premier governmental and academic commercial enterprise established in the Middle East Region in the newer field of Genetic Diagnosis. He apprised further that the GenaTi’s laboratories have been accredited internationally by the College of American Pathologists (CAP). This partnership has the capacity for providing a leading and effective role in a wide range of diagnostic and research services to the doctors and researchers from different Universities and Research Centers worldwide. He opined: with the help of GenaTi, spouses whose babies suffering from genetic disorder could have healthy offspring, thanks to the PGD techniques. There are many diagnostic and research services which could benefit the specialized and interested persons in the field of genome applications. A visit to GenaTi website (http://genati.com) on the webpage will answer many queries.